C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older
about
Detection of pleiotropy through a Phenome-wide association study (PheWAS) of epidemiologic data as part of the Environmental Architecture for Genes Linked to Environment (EAGLE) study.-174G/C polymorphism in the interleukin-6 promoter is differently associated with prostate cancer incidence depending on race.Genetic variation across C-reactive protein and risk of prostate cancer.Association of interleukin-6 (-174 G/C) polymorphism with the prostate cancer risk: A meta-analysis.Genetic variation in RNASEL associated with prostate cancer risk and progression.The interleukin-6 -174G/C polymorphism and prostate cancer risk: a systematic review and meta-analysis.Metabolic imbalance and prostate cancer progression.Inflammatory markers in population studies of aging.Elevated levels of circulating IL-7 and IL-15 in patients with early stage prostate cancer.Polymorphisms in inflammatory genes, plasma antioxidants, and prostate cancer risk.Interleukin-6 gene (IL-6): a possible role in brain morphology in the healthy adult brain.Variation in IL10 and other genes involved in the immune response and in oxidation and prostate cancer recurrenceAssociation of Plasma Heat Shock Protein 70, Interleukin 6, and Creatine Kinase Concentrations in a Healthy, Young Adult Population.Association between prediagnostic biomarkers of inflammation and endothelial function and cancer risk: a nested case-control study.Association between interleukin-6 polymorphisms and urinary system cancer risk: evidence from a meta-analysisInflammatory genetic markers of prostate cancer risk.Plasma C-reactive protein, genetic risk score, and risk of common cancers in the Atherosclerosis Risk in Communities study.High-sensitivity C-reactive protein and cancer.Quantitative analysis of the association between CRP rs2808630 and rs1417938 polymorphisms and cancer risk.Meta-analysis of the role of IL-6 rs1800795 polymorphism in the susceptibility to prostate cancer: Evidence based on 17 studies.Prediagnostic circulating markers of inflammation and risk of prostate cancer.Interleukin-6 gene -174G>C and -636G>C promoter polymorphisms and prostate cancer risk.Risk of prostate cancer is not associated with levels of C-reactive protein and other commonly used markers of inflammation.Genetic polymorphisms of IL-6 promoter in cancer susceptibility and prognosis: a meta-analysis.The Pathologic Role of Toll-Like Receptor 4 in Prostate Cancer.Interleukin-6 promoter variants, prostate cancer risk, and survivalEducation, tobacco smoking, alcohol consumption, and IL-2 and IL-6 gene polymorphisms in the survival of head and neck cancer
P2860
Q30874310-F90C7F1E-5AFE-4B9D-B4C3-AA01516EF65DQ33684259-F29DC460-CD62-41E4-B1B8-2724E6EA65F8Q33777217-03828FD7-8778-4DE7-8251-0447357651C4Q33932481-EE009CFC-5D61-416F-97FB-A015035C80CAQ34094981-79474A86-EED2-44F8-9934-D5E98AFEBA5AQ34239802-61BCE9C9-5F6C-4951-A950-0A004BCAE967Q34794028-0F5E226D-66BE-4A19-BFAF-EBA3C7EF29F3Q34995451-AD727FA1-A661-4839-9E52-D74670ADBF43Q35318562-0DE96C1E-73D4-442D-BF05-F8176EBE9972Q35516448-99BA3675-3D71-49F6-8B49-3D68E39A3C50Q36299394-D7A02C76-3B78-4777-A734-0E59C66D29E5Q36306209-E8172257-991E-4930-8937-09200B51E534Q36339558-48DE490D-4309-49AD-B2F2-05551264EB4BQ36486486-529F1D57-6676-4ADE-8338-D3F04BEEC126Q36525733-06305627-FF88-4436-8CE9-BAE7443B837CQ37328413-17128F80-C436-40D1-9AC7-2B96CB26ECCAQ37332118-775F000D-DDB6-44FA-8758-B7F0F6D14E9FQ37506191-8F060622-063D-439A-8F20-0936EBE9BA42Q42076173-13E507EF-2F62-48D4-8EC4-6BB91FB1103EQ42293538-FAC91428-DCAA-46D9-BD2E-5F0308F7D4DEQ43536797-560D2289-8C48-4B78-A1CB-A05BA3E7E451Q44788547-5D9CE527-75F2-42CC-93E4-90FE50C53436Q53149258-8A0E5B87-6D39-444F-8E7F-506C32CB3490Q55195036-709CAFC8-878A-440A-B0F0-E0A68CBF9FECQ55339148-988C8022-340C-4C76-B197-643405AEAE9EQ57265634-9CBF563E-C8B4-4484-9288-CD4FEAB3325DQ58857134-6D8D0AC2-D67F-42C2-A5A2-87EB1F3210E0
P2860
C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
C-reactive protein, interleuki ...... in men aged 65 years and older
@ast
C-reactive protein, interleuki ...... in men aged 65 years and older
@en
type
label
C-reactive protein, interleuki ...... in men aged 65 years and older
@ast
C-reactive protein, interleuki ...... in men aged 65 years and older
@en
prefLabel
C-reactive protein, interleuki ...... in men aged 65 years and older
@ast
C-reactive protein, interleuki ...... in men aged 65 years and older
@en
P2093
P2860
P1476
C-reactive protein, interleuki ...... in men aged 65 years and older
@en
P2093
Alexander P Reiner
Annette Fitzpatrick
Christopher Li
Christopher S Carlson
Janet L Stanford
Marvalyn DeCambre
Mary L Biggs
Melissa A Austin
P2860
P2888
P304
P356
10.1007/S10552-009-9320-4
P577
2009-03-08T00:00:00Z